Effect of rTPA (recombinant tissue Plasminogen Activator) in patients with ischemic stroke
Phase 2
Recruiting
- Conditions
- Cerebellar stroke.Cerebellar stroke syndrome
- Registration Number
- IRCT20160318027097N10
- Lead Sponsor
- Ardabil University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Patients with ischemic stroke
Referring to the hospital less than 4.5 hours
Indication of rtPA injection
with no evidence of hemorrhage on theinitial brain image
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The stroke clinical manifestations. Timepoint: Befor the intervention, 24 hours, 48 hours, 168 hours, 1 month, 2 months, 3 months after the intervention. Method of measurement: National Institutes Of Health Stroke Scale.
- Secondary Outcome Measures
Name Time Method